Moderna, Inc.
MRNA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $16 | $38 | $71 | $102 |
| - Cash | $2 | $3 | $3 | $7 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $15 | $36 | $69 | $96 |
| Revenue | $3 | $7 | $19 | $18 |
| % Growth | -53.3% | -63.7% | 6.4% | – |
| Gross Profit | $2 | $2 | $13 | $15 |
| % Margin | 54.2% | 31.5% | 71.3% | 85.2% |
| EBITDA | -$3 | -$3 | $10 | $14 |
| % Margin | -106.1% | -47.9% | 51.8% | 76.3% |
| Net Income | -$4 | -$5 | $8 | $12 |
| % Margin | -111.3% | -68.8% | 44.3% | 68.8% |
| EPS Diluted | -9.27 | -12.34 | 20.1 | 28.29 |
| % Growth | 24.9% | -161.4% | -29% | – |
| Operating Cash Flow | -$3 | -$3 | $5 | $14 |
| Capital Expenditures | -$1 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$4 | $5 | $13 |